Literature DB >> 6983156

Esophageal transection and paraesophagogastric devascularization performed as an emergency measure for uncontrolled variceal bleeding.

J Mir, J Ponce, E Morena, M Juan, V Garrigues, R Pina, J Berenguer.   

Abstract

Thirty patients with portal hypertension underwent as an emergency measure esophageal transection for uncontrolled variceal bleeding. Murphy's anastomotic button and Prioton's clip were used for the transection in 16 patients and the Androsov autosuture stapler gun in the remaining 14 patients. According to the classification of Child, four patients were listed as class A; five, class B, and 21, class C. The survivors have been observed from one to six years. Successful control of the esophageal hemorrhage was achieved in all patients. Immediate operative deaths, within one month, occurred in 17 patients. Five patients had a recurrence of varices. Bleeding recurred in three patients. The over-all survival incidence has been 11 of 30 patients. All survivors are free of hepatic encephalopathy. Transabdominal esophageal mucosal transection with devascularization appears to be satisfactory, but according to our experience, an early recurrence of varices could be expected if the Androsov autosuture stapler gun had been used for the transection.

Entities:  

Mesh:

Year:  1982        PMID: 6983156

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  3 in total

Review 1.  Experience with radical esophagogastric devascularization procedures (Sugiura) for variceal bleeding outside Japan.

Authors:  M Dagenais; B Langer; B R Taylor; P D Greig
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

2.  Emergency and elective sclerotherapy of oesophageal varices.

Authors:  A B Szczepanik; W J Rudowski
Journal:  Ann R Coll Surg Engl       Date:  1988-01       Impact factor: 1.891

3.  Long-term results of hemostatic gastric suture in the treatment of esophagogastric varices.

Authors:  R Romero-Torres
Journal:  World J Surg       Date:  1989 May-Jun       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.